Abstract
Abstract
Introduction and hypothesis
Variations in outcome measures and reporting of outcomes in trials on surgery for pelvic organ prolapse (POP) using synthetic mesh have been evaluated and reported. However, the quality of outcome reporting, methodology of trials and their publication parameters are important considerations in the process of development of Core Outcome Sets. We aimed to evaluate these characteristics in randomized controlled trials on surgery for POP using mesh.
Methods
Secondary analysis of randomized controlled trials on surgical treatments using synthetic mesh for POP previously included in a systematic review developing an inventory of reported outcomes and outcome measures. The methodological quality was investigated with the modified Jadad criteria. Outcome reporting quality was evaluated with the MOMENT criteria. Publication parameters included publishing journal, impact factor and year of publication.
Results
Of the 71 previously reviewed studies published from 2000 to 2017, the mean JADAD score was 3.59 and the mean MOMENT score was 4.63. Quality of outcomes (MOMENT) was related to methodological quality (JADAD) (rho = 0.662; p = 0.000) and to year of publication (rho = 0.262; p = 0.028).
Conclusions
Methodological quality and outcome reporting quality appear correlated. However, publication characteristics do not have strong associations with the methodological quality of the studies. Evaluation of the quality of outcomes, methodology and publication characteristics are all an indispensable part of a staged process for the development of Core Outcome and Outcome Measure Sets.
Publisher
Springer Science and Business Media LLC
Subject
Urology,Obstetrics and Gynecology
Reference14 articles.
1. Souders CP, Eilber KS, McClelland L, Wood LN, Soulders AR, Steiner V, et al. The truth behind transvaginal mesh litigation: devices, timelines, and provider characteristics. Female Pelvic Med Reconstr Surg. 2018;24(1):21–5.
2. Chughtai B, Sedrakyan A, Mao J, Eilber KS, Anger JT, Clemens JQ. Is vaginal mesh a stimulus of autoimmune disease? Am J Obstet Gynecol. 2017;216(5):495. e1-495.e7.
3. Karmakar D, Dwyer PL. Failure of expectations in vaginal surgery: lack of appropriate consent, goals and expectations of surgery. Curr Urol Rep. 2016;17(12):87.
4. Federal Register/Vol. 81 No. 2/Tuesday, January 5, 2016/Rules and Regulation FDA 21 CFR Part 884 Avalaible at https://www.gpo.gov/fdsys/pkg/FR-2016-11-22/pdf/FR-2016-11-22.pdf
5. de Mattos Lourenco TR, Pergialiotis V, Duffy JMN, Durnea C, Elfituri A, Haddad JM, et al. A systematic review on reporting outcomes and outcome measures in trials on synthetic mesh procedures for pelvic organ prolapse: urgent action is needed to improve quality of research. Neurourol Urodyn. 2019;38(2):509–24.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献